About Dhiti Omics
Dhiti Omics is a company based in Bengaluru (India) founded in 2014. Dhiti Omics has raised $278.39 thousand across 2 funding rounds from investors including Harkaran Dhingra, Raja Mugasimangalam and Vasanthammal. Dhiti Omics operates in a competitive market with competitors including Foundation Medicine, Personalis, Omniome, Novogene Corporation and MedGenome, among others.
- Headquarter Bengaluru, India
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Dhiti Omics Technologies Private Limited
- Date of Incorporation 24 Jun, 2014
- Jurisdiction Banglore, Karnataka, India
-
Annual Revenue
$150.99 K (USD)176.42as on Mar 31, 2022
-
Net Profit
-$20.55 K (USD)4.58as on Mar 31, 2022
-
EBITDA
-$9.4 K (USD)39.96as on Mar 31, 2022
-
Total Equity Funding
$278.39 K (USD)
in 2 rounds
-
Latest Funding Round
$105.1 K (USD), Angel Round
Oct 03, 2022
-
Investors
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Dhiti Omics
Dhiti Omics has successfully raised a total of $278.39K across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $105.1 thousand completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Dhiti Omics
Dhiti Omics has secured backing from 9 investors, including angel investors. Prominent investors backing the company include Harkaran Dhingra, Raja Mugasimangalam and Vasanthammal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
HD
Harkaran Dhingra |
-
|
Locked | Locked | Locked |
|
RM
Raja Mugasimangalam |
-
|
Locked | Locked | Locked |
|
V
Vasanthammal |
-
|
Locked | Locked | Locked |
Investor details for Dhiti Omics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dhiti Omics
Investment portfolio details for Dhiti Omics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dhiti Omics
Detailed financials for Dhiti Omics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dhiti Omics Comparisons
Peer comparison for Dhiti Omics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dhiti Omics
Dhiti Omics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Foundation Medicine, Personalis, Omniome, Novogene Corporation and MedGenome, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Genomic sequencing and diagnosis software is provided for healthcare.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
Genomic services and solutions with NGS expertise are provided.
|
|
| Locked | Locked | Locked |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| Locked | Locked | Locked |
New genome engineering technology is provided for treating multiple diseases.
|
Detailed competitors of Dhiti Omics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dhiti Omics
Complete news archive for Dhiti Omics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dhiti Omics
Dhiti Omics was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Dhiti Omics is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Dhiti Omics is a funded company, having raised a total of $278.39K across 2 funding rounds to date.
Annual revenue of Dhiti Omics is $150.99K as on Mar 31, 2022.
Dhiti Omics was founded in 2014 and is based in Bengaluru, India. Operations focus on the molecular diagnostics sector, where state-of-the-art methods such as Sanger Sequencing, Next Generation Sequencing, and Microarrays are utilized. These technologies are applied to analyze individual genomes and detect genetic indicators. Clinicians are supported in disease prediction, prevention, and informed patient decision-making through these services.
Dhiti Omics's top competitors include Foundation Medicine, MedGenome and Personalis.
Dhiti Omics has 9 investors. Key investors include Harkaran Dhingra, Raja Mugasimangalam, Vasanthammal, Umarani, and Saradha Periannan.
The valuation of Dhiti Omics is $1.74M as of Oct 2022.